Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering RNAs

Details for Australian Patent Application No. 2005313883 (hide)

Owner Alnylam Pharmaceuticals, Inc. Hartmann, G. Hornung, V. Endres, S.

Inventors Hartmann, Gunther; Hornung, Veit; Endres, Stefan; De Fougerolles, Antonin

Agent Griffith Hack

Pub. Number AU-B-2005313883

PCT Pub. Number WO2006/063252

Priority 60/634,849 09.12.04 US

Filing date 9 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 31 March 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/063252 Priority application(s): WO2006/063252

31 March 2011 Application Accepted

  Published as AU-B-2005313883

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005313887-Treatment using D-threo methylphenidate

2005313875-Laundry detergent composition with mixed builder system